Clariant Closes Companhia Brasileira de Bentonita Buy

Swiss specialty chemicals producer Clariant has closed its acquisition of the remaining 50% shares of Companhia Brasileira de Bentonita (CBB) from Geosol, its 50:50 joint venture partner.

Clariant said its decision to buy out its partner reflects its strategy to invest in emerging markets while also strengthening its presence in Brazil's Iron Ore Pelletizing (IOP) industry, where bentonite is used to bind iron ore for export.

The Swiss company said the acquisition also will allow it to strengthen its participation in the foundry and civil engineering markets, in which there is high demand for bentonite-derived products, as well as open up new fronts in the detergents and paper industries.

Based at Vitória da Conquista in the state of Bahia in northeastern Brazil, CBB owns a bentonite mine, a bentonite processing facility and state-of-the-art production plant, in addition to laboratories, storage facilities and an office building.

Sven Schultheis, head of Clariant’s Functional Minerals business unit, said the deal demonstrates the company’s commitment to the growing bentonite business in Latin America and is a further important step toward becoming a leading bentonite company.

Additionally, the takeover of CBB secures Clariant’s access to raw clays to supply customers in Latin America, added Sólon Ramos, who heads the business unit’s regional team.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.